<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02871713</url>
  </required_header>
  <id_info>
    <org_study_id>1021219</org_study_id>
    <nct_id>NCT02871713</nct_id>
  </id_info>
  <brief_title>A Randomized Controlled Trial Comparing Intrathecal Morphine With Quadratus Lumborum Block for Post-cesarean Delivery Analgesia</brief_title>
  <official_title>A Randomized Controlled Trial Comparing Intrathecal Morphine With Quadratus Lumborum Block as Part of a Multimodal Analgesia Strategy for Post-cesarean Delivery Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vishal Uppal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IWK Health Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nova Scotia Health Authority</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain after caesarean delivery (CD) can interfere with the moms' ability to look after her
      baby and may contribute to developing long term pain and disability. Women having a CD
      receive pain medication (morphine) as part of their spinal anesthetic to help with pain
      relief after surgery. Morphine works well however has several side effects such as nausea,
      vomiting and itching which may be severe enough to make it difficult to care for herself and
      her new baby. In some cases, morphine causes difficulty in passing urine within first
      24-hours of the CD requiring catheterization and thus restricting mobilization. The quadratus
      lumborum block (QLB) is a newer nerve block that uses local anaesthetic solution to numb the
      nerves carrying pain sensation from surgical incision site. QLB may be able to provide
      effective pain control without the side-effects associated with the spinal morphine. This
      study is to determine if women receiving QLB have as good pain control with fewer side
      effects than those who do receive the spinal morphine. Adequate pain control will be assessed
      by their pain scores and recovery in the 24 to 48 hours after CD. The side effect profile of
      the two techniques, quality of recovery and long term impact will also be compared during
      this study.

      In addition, we would like to compare the patients who received both analgesic regimens (ITM
      and QLB) with patients who received only one analgesic intervention (i.e. either ITM or QLB).
      Further, the study will help us answer if combining the two analgesic interventions if
      beneficial or not.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 30, 2017</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of recovery (QoR) score</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morphine equivalent consumption</measure>
    <time_frame>24 hours and 48 hours</time_frame>
    <description>morphine equivalent consumption in the 24-h and 48-h period after spinal insertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery (QoR) score</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of nausea/vomiting needing treatment</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of itching needing treatment.</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of respiratory depression needing treatment.</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worst pain scores</measure>
    <time_frame>24 hours</time_frame>
    <description>The primary outcome will be highest pain intensity during first 24-h as measured</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Intrathecal morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intrathecal morphine 100 mcg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quadratus lumborum block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral QLB with 20 ml of 0.5% ropivacaine per side (maximum total dose 3 mg/kg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrathecal morphine + Quadratus lumborum block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral QLB with 20 ml of 0.5% ropivacaine per side (maximum total dose 3 mg/kg) + Intrathecal morphine 100 mcg</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bilateral Quadratus lumborum block with 0.5% ropivacaine</intervention_name>
    <description>Bilateral Quadratus lumborum block with 0.5% ropivacaine</description>
    <arm_group_label>Quadratus lumborum block</arm_group_label>
    <arm_group_label>Intrathecal morphine + Quadratus lumborum block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intrathecal Morphine with 100 mcg morphine</intervention_name>
    <description>Intrathecal Morphine with 100 mcg morphine</description>
    <arm_group_label>Intrathecal morphine</arm_group_label>
    <arm_group_label>Intrathecal morphine + Quadratus lumborum block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-emergent CD with planned spinal anesthesia

          -  American Society of Anesthesia physical status class I &amp; II;

          -  Age ≥18 years;

          -  Term gestational age (≥37 weeks);

          -  Singleton pregnancy;

          -  English-speaking.

        Exclusion Criteria:

          -  Morbid Obesity (BMI ≥35 kg/m2);

          -  Subjects with significant obstetric or neonatal co-morbidities;

          -  Patient enrollment in another study involving medication within 30 days of CD;

          -  Any other condition, which may impair patients ability to co-operate with data
             collection;

          -  Patient height less than 152 cm (5'0&quot;);

          -  History of opioid tolerance or sensitivity;

          -  Intolerance to non-steroidal anti-inflammatory drugs (NSAIDs);

          -  Women with a history of illicit drug use or prescribed opioids or benzodiazepines.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vishal Uppal, FRCA</last_name>
    <phone>9024706627</phone>
    <email>Lorraine.Chiasson@iwk.nshealth.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dolores McKeen, FRCPC</last_name>
    <phone>9024706627</phone>
    <email>Lorraine.Chiasson@iwk.nshealth.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorraine Chiasson</last_name>
    </contact>
    <contact_backup>
      <email>Lorraine.Chiasson@iwk.nshealth.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Eisenach JC, Pan PH, Smiley R, Lavand'homme P, Landau R, Houle TT. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain. 2008 Nov 15;140(1):87-94. doi: 10.1016/j.pain.2008.07.011. Epub 2008 Sep 24.</citation>
    <PMID>18818022</PMID>
  </results_reference>
  <results_reference>
    <citation>Dahl JB, Jeppesen IS, Jørgensen H, Wetterslev J, Møiniche S. Intraoperative and postoperative analgesic efficacy and adverse effects of intrathecal opioids in patients undergoing cesarean section with spinal anesthesia: a qualitative and quantitative systematic review of randomized controlled trials. Anesthesiology. 1999 Dec;91(6):1919-27. Review.</citation>
    <PMID>10598635</PMID>
  </results_reference>
  <results_reference>
    <citation>Carvalho B. Respiratory depression after neuraxial opioids in the obstetric setting. Anesth Analg. 2008 Sep;107(3):956-61. doi: 10.1213/ane.0b013e318168b443. Review.</citation>
    <PMID>18713913</PMID>
  </results_reference>
  <results_reference>
    <citation>Loane H, Preston R, Douglas MJ, Massey S, Papsdorf M, Tyler J. A randomized controlled trial comparing intrathecal morphine with transversus abdominis plane block for post-cesarean delivery analgesia. Int J Obstet Anesth. 2012 Apr;21(2):112-8. doi: 10.1016/j.ijoa.2012.02.005. Epub 2012 Mar 10.</citation>
    <PMID>22410586</PMID>
  </results_reference>
  <results_reference>
    <citation>McKeen DM, George RB, Boyd JC, Allen VM, Pink A. Transversus abdominis plane block does not improve early or late pain outcomes after Cesarean delivery: a randomized controlled trial. Can J Anaesth. 2014 Jul;61(7):631-40. doi: 10.1007/s12630-014-0162-5. Epub 2014 Apr 24.</citation>
    <PMID>24764186</PMID>
  </results_reference>
  <results_reference>
    <citation>Abdallah FW, Laffey JG, Halpern SH, Brull R. Duration of analgesic effectiveness after the posterior and lateral transversus abdominis plane block techniques for transverse lower abdominal incisions: a meta-analysis. Br J Anaesth. 2013 Nov;111(5):721-35. doi: 10.1093/bja/aet214. Epub 2013 Jun 27. Review.</citation>
    <PMID>23811424</PMID>
  </results_reference>
  <results_reference>
    <citation>Blanco R, Ansari T, Girgis E. Quadratus lumborum block for postoperative pain after caesarean section: A randomised controlled trial. Eur J Anaesthesiol. 2015 Nov;32(11):812-8. doi: 10.1097/EJA.0000000000000299.</citation>
    <PMID>26225500</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2016</study_first_submitted>
  <study_first_submitted_qc>August 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2016</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nova Scotia Health Authority</investigator_affiliation>
    <investigator_full_name>Vishal Uppal</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>quadratus lumborum block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

